Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,394,676 papers from all fields of science
Search
Sign In
Create Free Account
astragaloside A
Known as:
astragaloside-A
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Narrower (3)
3beta,6alpha,16beta,20R,24S; astragaloside IV of astragaloside A
astragaloside IV
cyclosiversioside F
Broader (2)
Saponins
Triterpenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
[Astragaloside Ⅳ regulates Nrf2/Bach1/HO-1 signaling pathway and inhibits H9c2 cardiomyocyte injury induced by hypoxia-reoxygenation].
Ping Yang
,
Yuping Zhou
,
Xiuchun Chang
,
Feng Wang
,
Gao-Wen Li
Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
2019
Corpus ID: 198985240
Astragaloside Ⅳ(AS-Ⅳ) has protective effects against ischemia-reperfusion injury(IRI), but its mechanism of action has not yet…
Expand
2018
2018
[Effect and mechanism of astragaloside Ⅳ on Toll-like receptor pathway in fibrotic mice after renal ischemia-reperfusion].
Ruyi Yang
,
Qian Xu
,
+4 authors
C. Zhao
Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
2018
Corpus ID: 54366917
The aim of this paper is to study the effect of astragaloside Ⅳ on renal fibrosis mice with ischemia-reperfusion injury (IRI) and…
Expand
2017
2017
[Effect of astragaloside Ⅳ combined with Panax notoginseng saponins on cerebral ischemia-reperfusion injury and study of pharmacokinetics in rats].
Jing-Xian Li
,
Xiao-qian Yang
,
+4 authors
Xiao-ping Huang
Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
2017
Corpus ID: 5959347
The aim is to study the effect of astragaloside Ⅳ (AST Ⅳ) combined with Panax notoginseng saponins (PNS) on cerebral ischemia…
Expand
2013
2013
Study of protective effects of compatibility of astragaloside A with ligustrazine on cerebral ischemic reperfusion injury
Wang Yu
2013
Corpus ID: 77216700
Objective:To observe the protective effects of compatibihty of astragaloside A with ligustrazine on cerebral ischemia and…
Expand
2011
2011
Effect comparison of different formulation of Dang-Gui-Bu-Xu-Tang on myelosuppression mouse.
Suchun Yan
,
Yiqiang Xie
,
Bide Zhu
,
Yingguang Han
,
W. Guo
Asian Pacific Journal of Tropical Medicine
2011
Corpus ID: 3441592
2011
2011
Chuanxiongzine-astragaloside IV decreases IL-1β and Caspase-3 gene expressions in rat brain damaged by cerebral ischemia/reperfusion: a study of real-time quantitative PCR assay.
Zhenhong Zhu
,
H. Wan
,
Jin-hui Li
Sheng li xue bao : [Acta physiologica Sinica]
2011
Corpus ID: 23668518
The purpose of this study was to establish an absolute quantitative method to detect IL-1β and Caspase-3 gene expressions in rat…
Expand
2011
2011
[Effect of ERK1/2 signaling pathway on astragaloside IV protects H9c2 cells against H2O2-induced oxidative injury].
Yuan-yuan Wang
,
Yang Peng
,
Qi Zhang
,
Yan-na Wu
,
Junqiu Song
,
Yan-xia Liu
Zhongguo ying yong sheng li xue za zhi = Zhongguo…
2011
Corpus ID: 24411636
OBJECTIVE To investigate whether Astragaloside IV(AST) protects H9c2 cells against H2O2-induced oxidative injury partly through…
Expand
2010
2010
Studies on quality standard of Huangmuguben Pills
He Yu-yin
2010
Corpus ID: 76139629
Objective To establish the effective quality control standard of Huangmuguben Pills.MethodsBy TLC right for Rhizoma Atractylodis…
Expand
2009
2009
Pharmacokinetic study on different compatibilities of Dangguibuxue Tang
Lv Yu-ping
2009
Corpus ID: 75314395
AIM: To explore the changed regularity of the pharmacokinetic parameters in animal plasma of astragaloside Ⅳ and ferulic acid…
Expand
2005
2005
黃耆皂苷IV(astragaloside IV)對人類大腸癌細胞株(HT-29)細胞增殖和基質金屬蛋白酶(Matrix Metalloproteinase)基因表現的影響
陳光偉
,
蘇進成
,
林昭庚
2005
Corpus ID: 77017010
Malignant tumor (cancer) is the most important disease of the top ten causes of death in Taiwan. Among cancer types, colon cancer…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE